Objective
to compare the Cre8 EVO stent to the Resolute Onyx stent in patients with diabetes and CAD
Study
multicentre, open-label, randomised controlled non-inferiority trial
Population
diabetic cases with â¥50% stenosis in coronary lesions suitable for PCI
Endpoints
target lesion failure, which included cardiac death, target-vessel myocardial infarction, or clinically indicated target-lesion revascularisation
Conclusion
in patients with diabetes undergoing PCI, Cre8 EVO stents were non-inferior to Resolute Onyx stents in terms of composite outcome of target lesion failure
Romaguera et al. Eur Heart J. 2022; 43:1320-1330